Nathalie Dubois-Stringfellow Senior Vice President of Product Development and Management at Sangamo Therapeutics Associated Podcasts Sangamo’s gene therapy product candidate for Fabry disease shows continued tolerability and promise as an alternative to Enzyme Replacement Therapy
Sangamo’s gene therapy product candidate for Fabry disease shows continued tolerability and promise as an alternative to Enzyme Replacement Therapy